<!DOCTYPE html>
<html>
<body>
<h1>Artificial Intelligence in medicine </h1>
<h2>links</h2>
<Ul>
<li><a href="artificial intelligence main page.html">artificial intelligence main page</a></li>
  <li><a href="artificial intelligence in medicine.html">artificial imtelligence in medicine</a>
</li>
  <li><a href="artificial intelligence in industry.html">artificial imtelligence in industry</a>
</li>
  <li><a href="history of artificial intelligence.html">history of artificial intelligence</a>
</li>
<li><a href="future of artificial intelligence.html">future of artificial intelligence</a>
</li>
</ul>
<ol>
<li><h2>diagnose diseases</h2></li>
<b>Correctly diagnosing diseases takes years of medical training. Even then, diagnostics is often an arduous, time-consuming process. In many fields, the demand for experts far exceeds the available supply. This puts doctors under strain and often delays life-saving patient diagnostics.

Machine Learning – particularly Deep Learning algorithms – have recently made huge advances in automatically diagnosing diseases, making diagnostics cheaper and more accessible.</b>
<h2>how machines learn to diagnose</h2>
<b>Machine Learning algorithms can learn to see patterns similarly to the way doctors see them. A key difference is that algorithms need a lot of concrete examples – many thousands – in order to learn. And these examples need to be neatly digitized – machines can’t read between the lines in textbooks.

So Machine Learning is particularly helpful in areas where the diagnostic information a doctor examines is already digitized.</b>
<p>such as</p>
<ul>
<li><b>Detecting lung cancer or strokes based on CT scans</b></li>
<li><b>Assessing the risk of sudden cardiac death or other heart diseases based on electrocardiograms and cardiac MRI images</li></b>
<li><b>Classifying skin lesions in skin images</li></b>
<li><b>Finding indicators of diabetic retinopathy in eye images</li></b>
</ul>
<li><h2>develop drugs faster</h2></li>
<b>Devolping drugs is a famously costly procedure. A considerable lot of the systematic procedures associated with sedate improvement can be made progressively productive with Machine Learning. This can possibly shave off long periods of work and many millions in speculations.</b>
<img src="https://global-uploads.webflow.com/5d3ec351b1eba4332d213004/5d4c71d35c89802f30c1f22d_Drug_Development_Process.png">
<li><h2>personalize treatment</h2></li>
<b>Various patients react to medications and treatment plans in an unexpected way. So customized treatment can possibly expand patients' life expectancies. In any case, it's difficult to distinguish which variables should influence the decision of treatment. 

AI can robotize this confused measurable work – and help find which qualities demonstrate that a patient will have a specific reaction to a specific treatment. So the calculation can foresee a patient's plausible reaction to a specific treatment. 

The framework learns this by cross-referencing comparative patients and looking at their medications and results. The subsequent result forecasts make it a lot simpler for specialists to structure the correct treatment plan.</b>
<li><h2>improve gene editing</h2></li>
<img src="data:image/jpeg;base64,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">
<b>Bunched Regularly Interspaced Short Palindromic Repeats (CRISPR), explicitly the CRISPR-Cas9 framework for quality altering, is a major jump forward in our capacity to alter DNA cost successfully – and unequivocally, similar to a specialist. 

This strategy depends on short guide RNAs (sgRNA) to target and alter a particular area on the DNA. In any case, the guide RNA can fit numerous DNA areas – and that can prompt unintended reactions (off-target impacts). The cautious determination of guide RNA with the least risky symptoms is a significant bottleneck in the utilization of the CRISPR framework. 

AI models have been demonstrated to deliver the best outcomes with regards to foreseeing the level of both guide-target cooperations and off-target impacts for a given sgRNA. This can fundamentally accelerate the improvement of guide RNA for each locale of human DNA.</b>
</ol>
<body bgcolor="gray">
</body>
</html>








